Michael Harrison
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Michael Harrison sits in the upper quartile of US sponsors by registered trial count (#3,663 of 15,742 sponsors by registered trial count).
Michael Harrison: 3 sponsored US clinical trials, 1 recruiting.
Michael Harrison sponsors 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 2 completed. The most-studied condition in this pipeline is Obstructive Sleep Apnea, with 1 trials.
Upper-quartile sponsor footprint
Michael Harrison sits in the upper quartile of the sponsor corpus (#3,663 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
3 total, page 1 of 1
Magnetic Apnea Prevention(MAGNAP) Device to Treat Obstructive Sleep Apnea:First-In-Human Study of Feasibility and Safety
NCT02431507
Magnamosis First-in-human Study of Feasibility and Safety
NCT02043392
Multicenter Trial of Magnetic Mini-Mover for Pectus Excavatum
NCT01327274
Therapeutic Areas
What is open in the Michael Harrison pipeline
1 recruiting of 3 indexed (33% open); 2 completed (67%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Obstructive Sleep Apnea (1 trial), 0 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Michael Harrison: open-pipeline peers nationwide
Peers matched on 3 registered trials and 33% open enrollment, not the therapeutic-area sidebar.
Michael Harrison sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 3 trials (± recruiting share)
- 10xBio · 3 trials · 0% recruiting
- 22nd Century Group · 3 trials · 0% recruiting
- AA Secord · 3 trials · 0% recruiting
- AAADRS Clinical Research Center · 3 trials · 0% recruiting
Sponsors near 33% open enrollment (± trial volume)
- Aadi Bioscience · 33% recruiting · 9 trials
- Aaron Cook · 33% recruiting · 3 trials
- Abivax S.A. · 33% recruiting · 6 trials
- Actuated Medical · 33% recruiting · 3 trials
Related
What to do with this Michael Harrison page
3 registered trials is a research-attention snapshot, not an endorsement of Michael Harrison or any single study.
- 1 of Michael Harrison's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obstructive Sleep Apnea is the condition Michael Harrison studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obstructive Sleep Apnea trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Michael Harrison pipeline card: 3 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.